Michael S. Bereman

2.3k total citations
57 papers, 1.7k citations indexed

About

Michael S. Bereman is a scholar working on Molecular Biology, Spectroscopy and Neurology. According to data from OpenAlex, Michael S. Bereman has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Spectroscopy and 10 papers in Neurology. Recurrent topics in Michael S. Bereman's work include Mass Spectrometry Techniques and Applications (25 papers), Advanced Proteomics Techniques and Applications (20 papers) and Metabolomics and Mass Spectrometry Studies (12 papers). Michael S. Bereman is often cited by papers focused on Mass Spectrometry Techniques and Applications (25 papers), Advanced Proteomics Techniques and Applications (20 papers) and Metabolomics and Mass Spectrometry Studies (12 papers). Michael S. Bereman collaborates with scholars based in United States, Canada and Switzerland. Michael S. Bereman's co-authors include David C. Muddiman, Michael J. MacCoss, Brendan MacLean, Taufika Islam Williams, Joshua Beri, Birgit Schilling, Anna Zawadzka, Barbara Frewen, C. Ronald Kahn and Michael P. Cusack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Michael S. Bereman

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Bereman United States 23 987 738 134 131 114 57 1.7k
Eduard Sabidó Spain 30 1.7k 1.8× 424 0.6× 103 0.8× 69 0.5× 214 1.9× 108 2.5k
Feng Yang United States 25 2.0k 2.0× 796 1.1× 179 1.3× 54 0.4× 175 1.5× 87 2.7k
Ian Pike United Kingdom 28 1.5k 1.5× 758 1.0× 75 0.6× 176 1.3× 61 0.5× 66 2.7k
Mark E. Hemling United States 18 861 0.9× 635 0.9× 63 0.5× 80 0.6× 50 0.4× 27 1.7k
Owen S. Skinner United States 22 1.3k 1.4× 757 1.0× 109 0.8× 27 0.2× 27 0.2× 33 2.0k
Marta Artal‐Sanz Spain 21 1.6k 1.6× 280 0.4× 36 0.3× 47 0.4× 74 0.6× 37 2.2k
Thomas R. Hurd United States 22 1.7k 1.7× 137 0.2× 108 0.8× 32 0.2× 95 0.8× 31 2.4k
Mathias Dreger Germany 23 1.3k 1.3× 251 0.3× 38 0.3× 33 0.3× 52 0.5× 43 1.9k
Mathew Traini Australia 16 814 0.8× 385 0.5× 50 0.4× 34 0.3× 113 1.0× 25 1.3k
Martin Hermansson Finland 30 2.0k 2.0× 482 0.7× 72 0.5× 29 0.2× 60 0.5× 53 2.8k

Countries citing papers authored by Michael S. Bereman

Since Specialization
Citations

This map shows the geographic impact of Michael S. Bereman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Bereman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Bereman more than expected).

Fields of papers citing papers by Michael S. Bereman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Bereman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Bereman. The network helps show where Michael S. Bereman may publish in the future.

Co-authorship network of co-authors of Michael S. Bereman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Bereman. A scholar is included among the top collaborators of Michael S. Bereman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Bereman. Michael S. Bereman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsantilas, Kristine A., Gennifer E. Merrihew, Richard S. Johnson, et al.. (2024). A Framework for Quality Control in Quantitative Proteomics. Journal of Proteome Research. 23(10). 4392–4408. 10 indexed citations
2.
Bereman, Michael S., et al.. (2022). An experimental evaluation of the efficacy of perinatal sulforaphane supplementation to decrease the incidence and severity of vinclozolin-induced hypospadias in the mouse model. Toxicology and Applied Pharmacology. 451. 116177–116177. 2 indexed citations
3.
Bereman, Michael S., et al.. (2022). The Cyanotoxin 2,4-DAB Reduces Viability and Causes Behavioral and Molecular Dysfunctions Associated with Neurodegeneration in Larval Zebrafish. Neurotoxicity Research. 40(2). 347–364. 14 indexed citations
4.
Filiano, Anthony J., Xu Li, Leonard B. Collins, et al.. (2022). Filtered Cerebrospinal Fluid From Patients With Amyotrophic Lateral Sclerosis Displays an Altered Proteome and Affects Motor Phenotype in a Mouse Model. Cureus. 14(12). e32980–e32980. 6 indexed citations
5.
Bereman, Michael S., et al.. (2020). BMAA and MCLR Interact to Modulate Behavior and Exacerbate Molecular Changes Related to Neurodegeneration in Larval Zebrafish. Toxicological Sciences. 179(2). 251–261. 22 indexed citations
6.
Bereman, Michael S., Kaylie I. Kirkwood‐Donelson, Tharani Sabaretnam, et al.. (2020). Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-l-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis. Journal of Proteome Research. 19(8). 3276–3285. 17 indexed citations
7.
Bereman, Michael S., Joshua Beri, Jeffrey R. Enders, & Tara E. Nash. (2018). Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS. Scientific Reports. 8(1). 16334–16334. 33 indexed citations
8.
Wang, Ping, et al.. (2017). Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program. Nature Communications. 8(1). 82–82. 70 indexed citations
9.
Hoadley, Katherine A., Dereje D. Jima, Michael S. Bereman, et al.. (2016). Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis. Molecular Cancer Research. 15(2). 165–178. 21 indexed citations
10.
Bereman, Michael S., et al.. (2014). COMPARISON OF COMMERCIAL LC MS/MS COMPATIBLE DETERGENTS WITH SODIUM DEOXYCHOLATE FOR SHOTGUN PROTEOMICS. Journal of Proteins and Proteomics. 5(4). 3 indexed citations
11.
Bereman, Michael S., et al.. (2014). C/EBPα regulates CRL4Cdt2-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint. Cell Cycle. 13(22). 3602–3610. 20 indexed citations
12.
Bereman, Michael S., Daniela M. Tomazela, Hillary B. Heins, et al.. (2012). A method to determine the kinetics of multiple proteins in human infants with respiratory distress syndrome. Analytical and Bioanalytical Chemistry. 403(8). 2397–2402. 4 indexed citations
13.
Cilia, Michelle, Kari A. Peter, Michael S. Bereman, et al.. (2012). Discovery and Targeted LC-MS/MS of Purified Polerovirus Reveals Differences in the Virus-Host Interactome Associated with Altered Aphid Transmission. PLoS ONE. 7(10). e48177–e48177. 26 indexed citations
14.
Schilling, Birgit, Matthew J. Rardin, Brendan MacLean, et al.. (2012). Platform-independent and Label-free Quantitation of Proteomic Data Using MS1 Extracted Ion Chromatograms in Skyline. Molecular & Cellular Proteomics. 11(5). 202–214. 356 indexed citations
15.
Pierce, Sarah B., Cailyn H. Spurrell, Jessica B. Mandell, et al.. (2011). Garrod's fourth inborn error of metabolism solved by the identification of mutations causing pentosuria. Proceedings of the National Academy of Sciences. 108(45). 18313–18317. 11 indexed citations
16.
Bereman, Michael S., Jarrett D. Egertson, & Michael J. MacCoss. (2011). Comparison between procedures using SDS for shotgun proteomic analyses of complex samples. PROTEOMICS. 11(14). 2931–2935. 49 indexed citations
17.
Bereman, Michael S. & David C. Muddiman. (2011). N-Linked Global Glycan Profiling by NanoLC Mass Spectrometry. Methods in molecular biology. 790. 87–97. 1 indexed citations
18.
Bereman, Michael S. & David C. Muddiman. (2010). The effects of abundant plasma protein depletion on global glycan profiling using NanoLC FT-ICR mass spectrometry. Analytical and Bioanalytical Chemistry. 396(4). 1473–1479. 9 indexed citations
19.
Bereman, Michael S., et al.. (2008). Mass measurement accuracy comparisons between a double‐focusing magnetic sector and a time‐of‐flight mass analyzer. Rapid Communications in Mass Spectrometry. 22(10). 1563–1566. 8 indexed citations
20.
Bereman, Michael S., Leonard Nyadong, Facundo M. Fernández, & David C. Muddiman. (2006). Direct high‐resolution peptide and protein analysis by desorption electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Communications in Mass Spectrometry. 20(22). 3409–3411. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Sabidó Breakdown of academic impact, for papers by Feng Yang Breakdown of academic impact, for papers by Ian Pike Breakdown of academic impact, for papers by Mark E. Hemling Breakdown of academic impact, for papers by Owen S. Skinner Breakdown of academic impact, for papers by Marta Artal‐Sanz Breakdown of academic impact, for papers by Thomas R. Hurd Breakdown of academic impact, for papers by Mathias Dreger Breakdown of academic impact, for papers by Mathew Traini Breakdown of academic impact, for papers by Martin Hermansson
Rankless by CCL
2026